Participated · Equity · Jul 2026

Founded in 2022 by Guillaume Horreard and Margot Karlikow, En Carta Diagnostics is developing a rapid point-of-need molecular diagnostic platform in an affordable cassette format that the company says delivers laboratory-level PCR precision in about 30 minutes. The technology uses aptamers to bind targets with high affinity and specificity and is positioned to detect indications across genetic, pathogenic and veterinary applications. En Carta has achieved first-in-human use and is running two clinical trials for its flagship early Lyme disease test in Boston and Bialystok, and in January 2026 received FDA Breakthrough Device Designation. The company has a co-development and commercialisation agreement with AAZ totaling a €13 million commercial partnership to bring rapid molecular tests for chlamydia and gonorrhea to market with committed volumes over five years. En Carta plans to industrialise via a fabless model with Circum Medical for cost-efficient, high-volume manufacturing and to expand from Lyme detection into STI screening while pursuing regulatory approvals in Europe and the US.

Participated · Equity · Apr 2026

Founded in 2020, Nona offers an all-in-one SaaS platform that centralizes purchasing, order management, stock and production tracking, menu design, Plan de Maîtrise Sanitaire compliance and budget/environmental indicators for collective kitchens. The solution claims to save kitchen teams 3–4 hours per week and includes thousands of referenced local producers to ease procurement. Nona reports having equipped over 700 cantines and supporting the preparation of about 100,000 meals per day, with client sites showing much lower food waste (around 20 g per plate versus a national average of 120 g). The company also reports increases in vegetarian and seasonal recipes and projects significant environmental impact by 2025. Nona plans continued product investment, deeper producer relationships and expanded territorial accompaniment as it scales nationally.

Participated · Series A · Apr 2026

Five Lives offers a suite of digital therapeutic products, including Five Lives Brain Health for prevention and Five Lives Care, launched in early 2026, as a therapeutic solution for mild cognitive impairment. The platforms deliver over 500 adapted physical activity videos, cognitive games, language exercises, and personalized lifestyle recommendations with real-time difficulty adjustment. A randomized clinical trial of 180 participants across seven hospitals in the UK and France showed statistically significant improvements in executive function and quality of life after three months of use. The Care app is priced at €30 per month and has received recommendations from neurologists and geriatricians at leading French and British institutions. The company is pursuing reimbursement via France's PECAN digital therapy program with a target of 2027 and plans to integrate AI to further personalize sessions. Early traction includes 200,000 cumulative downloads and 5,000 active patients on the therapeutic app within two months, and Five Lives projects revenues of €400,000 in 2025, €1 million in 2026, and €5–10 million in 2027 upon reimbursement.

Participated · Equity · Feb 2026

Getinside provides software that lets medium-sized online retailers sell advertising inventory—known as retail media—by pooling their audiences so they can attract larger advertisers. The platform incorporates AI to automate campaign set-up and management, enabling the company to scale to thousands of merchants and advertisers without proportionally increasing headcount. Getinside currently works with more than 250 e-commerce merchants and 300 active advertisers that have executed 950 campaigns. The company generated €1.6 million in revenue in 2025 and is targeting €3 million by 2026. To support this growth, management plans to double its eight-person team and expand its advertising formats to include email post-purchase placements, product sampling, and social-media publications. By giving advertisers an alternative to GAFAM channels and allowing regional retailers to monetize traffic, Getinside positions itself as a democratizer of retail media.

Led · Equity · Jan 2026

Campsider operates a specialized marketplace for second-hand technical outdoor sports equipment such as bicycles, skis and snowboards. The platform partners exclusively with more than 600 sports stores across Europe that inspect, refurbish and provide a 12-month guarantee on listed items, positioning Campsider as a trusted intermediary for high-value gear. It currently serves a community of 200,000 athletes and has facilitated the sale of over 40,000 items, generating an annual gross merchandise volume of €10 million and growing 100 % year-on-year. Average basket sizes reach €2,000 for bikes and €200 for skis, with discounts up to 70 %. After achieving its first profitable month in December 2025, the company expects to be fully profitable in 2026 with projected revenue of €17 million. Looking ahead, Campsider plans to expand into Italy and Germany beginning in 2026, leveraging its digitized French inventory to seed new markets. By 2027 it targets €24 million in revenue, 30 % of which would come from outside France. Founded in 2020, the business operates from Lyon with staff also in Paris and Annecy.